131
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Associations Between Morphological Phenotypes of COPD and Clinical Characteristics in Surgically Resected Patients with COPD and Concomitant Lung Cancer

, ORCID Icon, , ORCID Icon, , , ORCID Icon, ORCID Icon & show all
Pages 1443-1452 | Published online: 21 Jun 2022

References

  • Gao YH, Guan WJ, Liu Q, et al. Impact of COPD and emphysema on survival of patients with lung cancer: a meta-analysis of observational studies. Respirology. 2016;21:269–279. doi:10.1111/resp.12661
  • Lin H, Lu Y, Lin L, Meng K, Fan J. Does chronic obstructive pulmonary disease relate to poor prognosis in patients with lung cancer? A meta-analysis. Medicine. 2019;98:e14837. doi:10.1097/MD.0000000000014837
  • Wang W, Dou S, Dong W, et al. Impact of COPD on prognosis of lung cancer: from a perspective on disease heterogeneity. Int J Chron Obstruct Pulmon Dis. 2018;13:3767–3776. doi:10.2147/COPD.S168048
  • Roy E, Rheault J, Pigeon MA, et al. Lung cancer resection and postoperative outcomes in COPD: a single-center experience. Chron Respir Dis. 2020;17:1479973120925430. doi:10.1177/1479973120925430
  • Okada Y, Hashimoto N, Iwano S, et al. Renewed Japanese spirometric reference variables and risk stratification for postoperative outcomes in COPD patients with resected lung cancer. Nagoya J Med Sci. 2019;81:427–438. doi:10.18999/nagjms.81.3.427
  • Kitaguchi Y, Fujimoto K, Kubo K, Honda T. Characteristics of COPD phenotypes classified according to the findings of HRCT. Respir Med. 2006;100:1742–1752. doi:10.1016/j.rmed.2006.02.003
  • Fujimoto K, Kitaguchi Y, Kubo K, Honda T. Clinical analysis of chronic obstructive pulmonary disease phenotypes classified using high-resolution computed tomography. Respirology. 2006;11:731–740. doi:10.1111/j.1440-1843.2006.00930.x
  • Wada Y, Kitaguchi Y, Yasuo M, et al. Diversity of respiratory impedance based on quantitative computed tomography in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:1841–1849. doi:10.2147/COPD.S163129
  • Johannessen A, Skorge TD, Bottai M, et al. Mortality by level of emphysema and airway wall thickness. Am J Respir Crit Care Med. 2013;187:602–608. doi:10.1164/rccm.201209-1722OC
  • Tho NV, Trang LT, Murakami Y, et al. Airway wall area derived from 3-dimensional computed tomography analysis differs among lung lobes in male smokers. PLoS One. 2014;9:e98335. doi:10.1371/journal.pone.0098335
  • Higami Y, Ogawa E, Ryujin Y, et al. Increased epicardial adipose tissue is associated with the airway dominant phenotype of chronic obstructive pulmonary disease. PLoS One. 2016;11:e0148794. doi:10.1371/journal.pone.0148794
  • Tanimura K, Sato S, Fuseya Y, et al. Quantitative assessment of erector spinae muscles in patients with chronic obstructive pulmonary disease. Novel chest computed tomography-derived index for prognosis. Ann Am Thorac Soc. 2016;13:334–341. doi:10.1513/AnnalsATS.201507-446OC
  • Tanimura K, Sato S, Sato A, et al. Accelerated loss of antigravity muscles is associated with mortality in patients with COPD. Respiration. 2020;99:298–306. doi:10.1159/000506520
  • Goldstraw P, Crowley J, Chansky K, et al; International Association for the Study of Lung Cancer International Staging Committee; Participating institutions. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol. 2007;2:706–714. doi:10.1097/JTO.0b013e31812f3c1a
  • Global Initiative for Chronic Obstructive Lung Disease [homepage on the Internet]. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHOWorkshop report. Bethesda, MD: National Heart, Lung and Blood Institute; 2001. Available from: http://www.goldcopd.com. Accessed January 1, 2022.
  • Shoji F, Morodomi Y, Akamine T, et al. Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer. Lung Cancer. 2016;98:15–21. doi:10.1016/j.lungcan.2016.05.010
  • Bar-Ad V, Palmer J, Li L, et al. Neutrophil to lymphocyte ratio associated with prognosis of lung cancer. Clin Transl Oncol. 2017;19:711–717. doi:10.1007/s12094-016-1593-y
  • Ding N, Pang Z, Shen H, Ni Y, Du J, Liu Q. The prognostic value of PLR in lung cancer, a meta-analysis based on results from a large consecutive cohort. Sci Rep. 2016;6:34823. doi:10.1038/srep34823
  • Jafri SH, Shi R, Mills G. Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review. BMC Cancer. 2013;13:158. doi:10.1186/1471-2407-13-158
  • Kurishima K, Watanabe H, Ishikawa H, Satoh H, Hizawa N. Modified Glasgow prognostic score in patients with small-cell lung cancer. Mol Clin Oncol. 2017;7:121–124. doi:10.3892/mco.2017.1261
  • Kasymjanova G, MacDonald N, Agulnik JS, et al. The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer. Curr Oncol. 2010;17:52–58. doi:10.3747/co.v17i4.567
  • Kitaguchi Y, Komatsu Y, Fujimoto K, Hanaoka M, Kubo K. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma. Int J Chron Obstruct Pulmon Dis. 2012;7:283–289. doi:10.2147/COPD.S30651
  • Kitaguchi Y, Yasuo M, Hanaoka M. Comparison of pulmonary function in patients with COPD, asthma-COPD overlap syndrome, and asthma with airflow limitation. Int J Chron Obstruct Pulmon Dis. 2016;11:991–997. doi:10.2147/COPD.S105988
  • Goddard PR, Nicholson EM, Laszlo G, Watt I. Computed tomography in pulmonary emphysema. Clin Radiol. 1982;33:379–387. doi:10.1016/S0009-9260(82)80301-2
  • Asakura T, Yamada Y, Suzuki S, et al. Quantitative assessment of erector spinae muscles in patients with Mycobacterium avium complex lung disease. Respir Med. 2018;145:66–72. doi:10.1016/j.rmed.2018.10.023
  • Minegishi Y, Inoue S, Sato K, et al. Smaller erector spinae muscle size is associated with inability to recover activities of daily living after pneumonia treatment. Respir Investig. 2019;57:191–197. doi:10.1016/j.resinv.2018.11.002
  • Caramori G, Casolari P, Cavallesco GN, Giuffrè S, Adcock I, Papi A. Mechanisms involved in lung cancer development in COPD. Int J Biochem Cell Biol. 2011;43:1030–1044. doi:10.1016/j.biocel.2010.08.022
  • Smith BM, Schwartzman K, Kovacina B, et al. Lung cancer histologies associated with emphysema on computed tomography. Lung Cancer. 2012;76:61–66. doi:10.1016/j.lungcan.2011.09.003
  • Grydeland TB, Dirksen A, Coxson HO, et al. Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking. Eur Respir J. 2009;34:858–865. doi:10.1183/09031936.00167908
  • Karayama M, Inui N, Mori K, et al. Respiratory impedance is correlated with morphological changes in the lungs on three-dimensional CT in patients with COPD. Sci Rep. 2017;7:41709. doi:10.1038/srep41709
  • Nakano Y, Wong JC, de Jong PA, et al. The prediction of small airway dimensions using computed tomography. Am J Respir Crit Care Med. 2005;171:142–146. doi:10.1164/rccm.200407-874OC
  • Fernandes L, Fernandes Y, Mesquita AM. Quantitative computed tomography imaging in chronic obstructive pulmonary disease. Lung India. 2016;33:646–652. doi:10.4103/0970-2113.192880
  • Awano N, Inomata M, Kuse N, et al. Quantitative computed tomography measures of skeletal muscle mass in patients with idiopathic pulmonary fibrosis according to a multidisciplinary discussion diagnosis: a retrospective nationwide study in Japan. Respir Investig. 2020;58:91–101. doi:10.1016/j.resinv.2019.11.002